Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Varga

Showing results (431-440 of 445) with videos related to

Pageof 45
Sort By:
Genome Announcements|October 19, 2013
Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7John J Varga, Liliana Losada, Adrian M Zelazny, et al.
Pathology Oncology Research : POR|December 4, 2019
Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center AnalysisA Kocsis, L Karsko, Zs Kurgyis, et al.
Studies in Mycology|December 11, 2014
Phylogeny, identification and nomenclature of the genus AspergillusR A Samson, C M Visagie, J Houbraken, et al.
Annals of Internal Medicine|February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
HGG Advances|September 18, 2023
BRCA1 frameshift variants leading to extended incorrect protein C terminiThales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, et al.
HGG Advances|April 26, 2024
BRCA1 frameshift variants leading to extended incorrect protein C terminiThales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.
Arthritis and Rheumatism|November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialP J Clements, E L Hurwitz, W K Wong, et al.
Pageof 45

Showing results (431-440 of 445) with videos related to

Sort By:
Pageof 45
Genome Announcements|October 19, 2013
Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7John J Varga, Liliana Losada, Adrian M Zelazny, et al.
Pathology Oncology Research : POR|December 4, 2019
Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center AnalysisA Kocsis, L Karsko, Zs Kurgyis, et al.
Studies in Mycology|December 11, 2014
Phylogeny, identification and nomenclature of the genus AspergillusR A Samson, C M Visagie, J Houbraken, et al.
Annals of Internal Medicine|February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
HGG Advances|September 18, 2023
BRCA1 frameshift variants leading to extended incorrect protein C terminiThales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, et al.
HGG Advances|April 26, 2024
BRCA1 frameshift variants leading to extended incorrect protein C terminiThales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.
Arthritis and Rheumatism|November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialP J Clements, E L Hurwitz, W K Wong, et al.
Pageof 45